Long-Term Assets (Annual)

Long-Term Assets: The sum of all assets classified as non-current.

ClearPoint Neuro, Inc. (CLPT) had Long-Term Assets of $6.49M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$23.95M
Net Income	$-22.09M
Cost of Goods Sold	$10.34M
Gross Profit	$13.61M
Operating Expenses	$46.40M
Operating Income	$-22.45M
Non-Operating Income/Expense	$0.36M
Pre-Tax Income	$-22.09M
Normalized Pre-Tax Income	$-22.09M
Income after Taxes	$-22.09M
Income from Continuous Operations	$-22.09M
Consolidated Net Income/Loss	$-22.09M
Normalized Income after Taxes	$-22.09M
EBIT	$-22.45M
EBITDA	$-20.93M
Weighted-Average Shares Outstanding (Basic)	24.61M
Weighted-Average Shares Outstanding (Diluted)	24.61M
Earnings per Share (EPS) (Basic)	$-0.90
Earnings per Share (EPS) (Diluted)	$-0.90
Balance Sheet Financials
Current Assets	$36.17M
Property, Plant, and Equipment	$1.39M
Long-Term Assets	$6.49M
Total Assets	$42.66M
Current Liabilities	$7.43M
Long-Term Debt	$9.95M
Long-Term Liabilities	$14.06M
Total Liabilities	$21.49M
Common Equity	$21.17M
Tangible Shareholders Equity	$20.79M
Shareholders Equity	$21.17M
Common Shares Outstanding	24.65M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-13.72M
Cash Flow from Investing Activities	$8.95M
Cash Flow from Financial Activities	$0.30M
Beginning Cash	$27.61M
End Cash	$23.14M
Increase/Decrease in Cash	$-4.47M
Stock-Based Compensation	$6.08M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.47
Gross Margin	56.83%
Operating Margin	-93.70%
EBIT Margin	-93.70%
EBITDA Margin	-87.38%
Pre-Tax Profit Margin	-92.21%
Profit Margin	-92.21%
Free Cash Flow	$-14.44M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.56
Inventory Turnover	1.31
Receiveable Turnover	7.46
Days Sales in Receivables	48.93
Return on Equity	-104.33%
Return on Tangible Equity	-106.26%
Return on Assets	-51.78%
Return on Investments	-70.98%
Book Value Per Share	$0.86
Free Cash Flow per Share	$-0.59
Operating Cash Flow per Share	$-0.56

Data from Zacks Investment Research, Inc.